Davide Anchisi

Davide Anchisi

Auto-generated profile, based on publicly available information

Davide Anchisi

Department of Medicine, University of Udine, Udine, Italy

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2002 in NeuroImage
Verified
Journal Article
Closed access
KHK Herholz
K Herholz
ESEric Salmon
Eric Salmon
DPD Perani
D Perani
Claude BaronClaude Baron
Claude Baron
VHV Holthoff
V Holthoff
WHW D Heiss
W D Heiss

1 November 2005 in Archives of Neurology
Verified
Journal Article
Open access
PDF file
DADavide Anchisi
Davide Anchisi
BBBarbara Borroni
Barbara Borroni
MFMassimo Franceschi
Massimo Franceschi
NKNasser Kerrouche
Nasser Kerrouche
EKElke Kalbe
Elke Kalbe
DPDaniela Perani
Daniela Perani
Mild cognitive impairment (MCI) is a diagnostic entity used to describe defective memory performances that do not fulfill the criteria for dementia.1 Mild cognitive impairment includes incipient Alzheimer disease (AD) and other causes of dementia, as well as a form of cognitive impairment that does not progress to dementia and may disappear. This entity has been redefined to include amnesic MCI (aMCI) and nonamnesic MCI, according to the presence of an isolated objective memory deficit or of multiple or isolated extramemory cognitive impairment.2 This variation in MCI has been evaluated using neuroimaging3-5 and biologic markers.6,7 Results of clinical studies5,8 have suggested that neuropsychological tests, especially those evaluating delayed recall, might play an important role in identifying early or preclinical AD among subjects with MCI. These studies, however, were conducted among small groups of subjects.

24 January 2005 in Annals of Neurology
Verified
Journal Article
Closed access
PDF file
MFMassimo Franceschi
Massimo Franceschi
DADavide Anchisi
Davide Anchisi
OPOriana Pelati
Oriana Pelati
MZMarta Zuffi
Marta Zuffi
MMMario Matarrese
Mario Matarrese
DPDaniela Perani
Daniela Perani

1 December 2010 in Pain
Verified
Journal Article
Closed access
FLFausta Lui
Fausta Lui
LCLuana Colloca
Luana Colloca
DDDavide Duzzi
Davide Duzzi
DADavide Anchisi
Davide Anchisi
FBFabrizio Benedetti
Fabrizio Benedetti
CPCarlo Adolfo Porro
Carlo Adolfo Porro
Despite growing interest in the placebo effect, the neural correlates of conditioned analgesia are still incompletely understood. We investigated herein on brain activity during the conditioning and post-conditioning phases of a placebo experimental paradigm, using event-related fMRI in 31 healthy volunteers. Brief laser heat stimuli delivered to one foot (either right or left) were preceded by different visual cues, signalling either painful stimuli alone, or painful stimuli accompanied by a (sham) analgesic procedure. Cues signalling the analgesic procedure were followed by stimuli of lower intensity in the conditioning session, whereas in the test session both cues were followed by painful stimuli of the same intensity. During the first conditioning trials, progressive signal increases over time were found during anticipation of analgesia compared to anticipation of pain, in a medial prefrontal focus centered on medial area BA8, and in bilateral lateral prefrontal foci. These frontal foci were adjacent to, and partially overlapped, those active during anticipation of analgesia in the test session, whose signal changes were related to the magnitude of the placebo behavioral response, and those active during placebo analgesia. Specifically, a large focus in the right prefrontal cortex showed activity related to analgesia, irrespective of the expected side of stimulation. Analgesia was also related to decreased activity, detectable immediately following noxious stimulation, in parietal, insular and cingulate pain-related clusters. Our findings of dynamic changes in prefrontal areas during placebo conditioning, and of direct placebo effects on cortical nociceptive processing, add new insights into the neural bases of conditioned placebo analgesia.

1 August 1998 in Journal of Neurophysiology
Verified
Journal Article
Closed access
PDF file
FTFilippo Tempia
Filippo Tempia
MMMaria Concetta Miniaci
Maria Concetta Miniaci
DADavide Anchisi
Davide Anchisi
PSPiergiorgio Strata
Piergiorgio Strata
Tempia, Filippo, Maria Concetta Miniaci, Davide Anchisi, and Piergiorgio Strata. Postsynaptic current mediated by metabotropic glutamate receptors in cerebellar Purkinje cells. J. Neurophysiol. 80: 520–528, 1998. In rat cerebellar slices, repetitive parallel fiber stimulation evokes an inward, postsynaptic current in Purkinje cells with a fast component mediated by α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)/kainate receptors and a slower component mediated by metabotropic glutamate receptors (mGluR). The mGluR-mediated excitatory postsynaptic current (mGluR-EPSC) is evoked selectively by parallel fiber stimulation; climbing fiber stimulation is ineffective. The mGluR-EPSC is elicited most effectively with increasing frequencies of parallel fiber stimulation, from a threshold of 10 Hz to a maximum response at ∼100 Hz. The amplitude of the mGluR-EPSC is a linear function of the number of stimulus pulses without any apparent saturation, even with >10 pulses. Thus mGluRs at the parallel fiber-Purkinje cell synapse can function as linear detectors of the number of spikes in a burst of activity in parallel fibers. The mGluR-EPSC is present from postnatal day 15 and persists into adulthood. It is inhibited by the generic mGluR antagonist (RS)-a-methyl-4-carboxyphenylglycine and by the group I mGluR antagonist (RS)-1-aminoindan-1,5-dicarboxylic acid at a concentration selective for mGluR1. Although the intracellular transduction pathway involves a G protein, the putative mediators of mGluR1 (phospholipase C and protein kinase C) are not directly involved, indicating that the mGluR-EPSC studied here is mediated by a different and still unidentified second-messenger pathway. Heparin, a nonselective antagonist of inositol-trisphosphate (IP3) receptors, has no significant effect on the mGluR-EPSC, suggesting that also IP3might be not required for the response. Buffering intracellular Ca2+with a high concentration of bis-( o-aminophenoxy)- N,N,N′,N′-tetraacetic acid partially inhibits the mGluR-EPSC, indicating that Ca2+is not directly responsible for the response but that resting Ca2+levels exert a tonic potentiating effect on the mGluR-EPSC.

1 January 2006 in Neurobiology of Aging
Verified
Journal Article
Closed access
BBBarbara Borroni
Barbara Borroni
DAD. Anchisi
D. Anchisi
BPB. Paghera
B. Paghera
BVB. Vicini
B. Vicini
NKN. Kerrouche
N. Kerrouche
DPD. Perani
D. Perani